10x Genomics, Inc. Annual Income Tax Expense (Benefit) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
10x Genomics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2017 to 2023.
  • 10x Genomics, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $818K, a 50.3% decline year-over-year.
  • 10x Genomics, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $6.56M, a 21% increase year-over-year.
  • 10x Genomics, Inc. annual Income Tax Expense (Benefit) for 2023 was $6.34M, a 57.3% increase from 2022.
  • 10x Genomics, Inc. annual Income Tax Expense (Benefit) for 2022 was $4.03M, a 10.6% decline from 2021.
  • 10x Genomics, Inc. annual Income Tax Expense (Benefit) for 2021 was $4.51M, a 45.4% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $6.34M +$2.31M +57.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-15
2022 $4.03M -$479K -10.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-15
2021 $4.51M -$3.75M -45.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $8.26M +$8.04M +3687% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-16
2019 $218K +$131K +151% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-18
2018 $87K +$66K +314% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 $21K Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.